Evidence map›Paper›PMID 36094434›Full record

ArticleAmerican journal of physiology. Cell physiology2022

Development of skeletal muscle atrophy and intermuscular adipose tissue in patients with early breast cancer treated with chemotherapy.

Joris Mallard, Elyse Hucteau, Laura Bender, Anouk Charlot, Léa Debrut, Carole Pflumio, Philippe Trensz, Roland Schott, Fabrice Favret, Xavier Pivot and 2 more

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04638712 nacompletednot on this map

Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients

TypeinterventionalSponsorInstitut de cancérologie Strasbourg EuropeRan2020 to 2021Enrolled13ConditionsBreast CancerArmsMicrobiopsy sample, Muscle echography, Maximal strength, Body composition, Quality of life and Physical activity level
NCT06536556 terminatednot on this mapstarted 2024, after this paper: background citation

Effects of a Single Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: Comparison of Paclitaxel vs Paclitaxel + Trastuzumab vs Paclitaxel + Carboplatine: the PROTECT-06 Bis Study

TypeobservationalSponsorInstitut de cancérologie Strasbourg EuropeRan2024 to 2025Enrolled5ConditionsBreast CancerArmsFirst Assessment, Second Assessment
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Joris MallardFaculté de médecine, maïeutique et sciences de la santé, "Mitochondrie, Stress oxydant, Protection musculaire," Université de Strasbourg, Strasbourg, France.
Elyse HucteauFaculté de médecine, maïeutique et sciences de la santé, "Mitochondrie, Stress oxydant, Protection musculaire," Université de Strasbourg, Strasbourg, France.
Laura BenderInstitut de Cancérologie Strasbourg Europe (ICANS), Strasbourg, France.
Anouk CharlotFaculté de médecine, maïeutique et sciences de la santé, "Mitochondrie, Stress oxydant, Protection musculaire," Université de Strasbourg, Strasbourg, France.ORCID 0000-0002-4731-3106
Léa DebrutFaculté de médecine, maïeutique et sciences de la santé, "Mitochondrie, Stress oxydant, Protection musculaire," Université de Strasbourg, Strasbourg, France.
Carole PflumioInstitut de Cancérologie Strasbourg Europe (ICANS), Strasbourg, France.
Philippe TrenszInstitut de Cancérologie Strasbourg Europe (ICANS), Strasbourg, France.
Roland SchottInstitut de Cancérologie Strasbourg Europe (ICANS), Strasbourg, France.ORCID 0000-0002-7735-5366
Fabrice FavretFaculté de médecine, maïeutique et sciences de la santé, "Mitochondrie, Stress oxydant, Protection musculaire," Université de Strasbourg, Strasbourg, France.ORCID 0000-0002-2827-9758
Xavier PivotInstitut de Cancérologie Strasbourg Europe (ICANS), Strasbourg, France.
Thomas J HureauFaculté de médecine, maïeutique et sciences de la santé, "Mitochondrie, Stress oxydant, Protection musculaire," Université de Strasbourg, Strasbourg, France.ORCID 0000-0002-6993-5723
Allan F PaganoFaculté de médecine, maïeutique et sciences de la santé, "Mitochondrie, Stress oxydant, Protection musculaire," Université de Strasbourg, Strasbourg, France.ORCID 0000-0003-0717-2377
Institut de Cancérologie Strasbourg · FRMitochondrie, stress oxydant et protection musculaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy is a common therapy to treat patients with breast cancer but also leads to skeletal muscle deconditioning. Skeletal muscle deconditioning is multifactorial and intermuscular adipose tissue (IMAT) accumulation is closely linked to muscle dysfunction. To date, there is no clinical study available investigating IMAT development through a longitudinal protocol and the underlying mechanisms remain unknown. Our study was dedicated to investigating IMAT content in patients with early breast cancer who were treated with chemotherapy and exploring the subsequent cellular mechanisms involved in its development. We included 13 women undergoing chemotherapy. Muscle biopsies and ultrasonography assessment were performed before and after chemotherapy completion. Histological and Western blotting analyses were conducted. We found a substantial increase in protein levels of three mature adipocyte markers (perilipin, +901%; adiponectin, +135%; FABP4, +321%;

Indexed as

Breast NeoplasmsAdiponectinAdipose TissueFemaleHumansMuscle, SkeletalMuscular AtrophyPerilipinsReceptor, Platelet-Derived Growth Factor alphaAdiponectinPerilipinsReceptor, Platelet-Derived Growth Factor alphafatty infiltrationsfibro-adipogenic progenitors (FAPs)intermuscular adipose tissue (IMAT)muscle architectureskeletal muscle deconditioning

Identifiers

PMID36094434
PMCPMC9576176
OpenAlexW4296554891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.